About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Chicago | 101 Studies

Clinical Trials Brain CancerChicago

Brain Cancer Clinical Trials in Chicago

Find 101 clinical trials for brain cancer near Chicago, Illinois. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 101 trials

CompletedDasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeDasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It may also make tumor cells more sensitive to radiation therapy.NCT00869401·Hartford, Connecticut and 206 others

Brain Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

UnknownCT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma MultiformeRationale: In light of the demonstrated activity of anti-angiogenesis agents in rGBM, it is reasonable to postulate that adding these agents to standard RT and chemotherapy in…NCT00768911·Little Rock, Arkansas and 5 others

CompletedThe PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma MultiformeThe purpose of the PRECISE trial is to determine whether overall survival duration, safety, and quality of life are improved for patients treated with IL13-PE38QQR compared to…NCT00076986·Birmingham, Alabama and 59 others

TerminatedImetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsThis molecular biology and phase II trial studies how well imetelstat sodium works in treating younger patients with recurrent or refractory brain tumors.NCT01836549·Los Angeles, California and 10 others

CompletedCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyThis phase II trial studies how well cilengitide works in treating younger patients with recurrent or progressive high-grade glioma that has not responded to standard therapy.NCT00679354·Oakland, California and 19 others

CompletedRadiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00304031·Fairbanks, Alaska and 350 others

TerminatedVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryThis randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be…NCT01814813·Anchorage, Alaska and 416 others

RecruitingLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionThe goal of this study is to determine the response of the study drug loratinib in treating children who are newly diagnosed high-grade glioma with a fusion in ALK or ROS1.NCT06333899·Aurora, Colorado and 17 others

TerminatedImatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaPhase I/II trial to estimate the maximum tolerated dose of imatinib mesylate in newly diagnosed brain stem gliomas and recurrent high grade gliomas and to assess the effectiveness…NCT00021229·San Francisco, California and 9 others

CompletedStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsThe purpose of this study was to investigate the activity of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive low…NCT02684058·Orange, California and 56 others

CompletedTemozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsRATIONALE: Drugs used in chemotherapy, such as temozolomide, vincristine, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or…NCT00138216·Birmingham, Alabama and 17 others

RecruitingPhase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaBrain tumor treatment is hampered by the blood-brain barrier (BBB). This barrier prevents drugs carried in the bloodstream from getting into the brain.NCT05864534·Chicago, Illinois

CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsThis phase I trial is studying the side effects and best dose of vorinostat when given together with temozolomide in treating young patients with relapsed or refractory primary…NCT01076530·Chicago, Illinois and 8 others

WithdrawnStudying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System TumorsRATIONALE: Studying samples of cerebrospinal fluid from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.NCT00897858·Washington D.C., District of Columbia and 7 others

CompletedPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaThis 2-arm, randomized, phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine that may act to promote…NCT01480479·Birmingham, Alabama and 222 others

Active not recruitingGammaTile and Stupp in Newly Diagnosed GBMIn summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local control or prolonged overall survival.NCT05342883·Scottsdale, Arizona and 15 others

CompletedEffect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)The study is a randomized, controlled trial, designed to test the efficacy and safety of a new medical device, the NovoTTF-100A.NCT00379470·Chicago, Illinois and 24 others

CompletedVeliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasThis phase I/II trial studies the side effects and the best dose of veliparib when given together with radiation therapy and temozolomide and to see how well they work in treating…NCT01514201·Los Angeles, California and 11 others

CompletedSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasThis phase I trial studies the side effects and best dose of selinexor in treating younger patients with solid tumors or central nervous system (CNS) tumors that have come back…NCT02323880·Birmingham, Alabama and 22 others

CompletedA Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationThis study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs…NCT02573324·Phoenix, Arizona and 211 others

PreviousPage 5 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia